CBZ vs EXPO

Key Takeaways

• CBIZ, Inc. (CBZ) has delivered robust year-to-date (YTD) returns of approximately 40%, significantly outperforming the S&P 500, driven by recent earnings momentum.
• Exponent, Inc. (EXPO) shows modest YTD gains around 4-5%, reflecting stability in the consulting sector with lower volatility (beta of 0.80).
• CBZ trades at a lower price-to-earnings (P/E) ratio of about 18 compared to EXPO's 32, suggesting better relative valuation for growth-oriented investors.
• Recent CBZ Q1 2026 earnings featured revenue growth of 1.3% to $849 million and EPS (earnings per share) of $2.63, beating estimates despite a slight revenue miss.
• Both stocks operate in professional services, but CBZ emphasizes financial and insurance advisory, while EXPO focuses on science and engineering consulting.
• Market caps differ: CBIZ at ~$1.8 billion versus EXPO's ~$3.2 billion, influencing liquidity and risk profiles.

Introduction

This stock comparison examines CBZ and EXPO, two players in the professional services sector offering advisory and consulting expertise. Traders seeking momentum may eye CBIZ's recent outperformance, while those prioritizing stability might prefer EXPO's consistent returns and lower volatility. Investors comparing relative performance, valuation, and sector exposure in today's market—marked by earnings season and economic uncertainty—will find insights into growth drivers, risks, and positioning. This analysis draws on recent financial data to highlight contrasts for informed decision-making in stock selection.

CBZ Overview and Recent Performance

CBIZ, Inc. (CBZ) is a leading provider of financial advisory, insurance brokerage, and valuation services to middle-market businesses across the U.S. and Canada. In recent market activity, CBZ shares have shown strong YTD returns exceeding 40%, outpacing the S&P 500 benchmark. The stock recently reported Q1 2026 results with revenue of $849 million, up 1.3% year-over-year, and adjusted EPS of $2.63, surpassing analyst expectations despite a minor revenue shortfall. The company raised its full-year adjusted EBITDA guidance to $465-475 million, signaling confidence amid organic growth and strategic acquisitions. Sentiment has been buoyed by improved profitability and free cash flow, though shares experienced volatility post-earnings, trading around $30 with a 52-week range of $24-78. Factors like sector demand for advisory services in a dynamic economy have supported momentum, tempered by integration costs from mergers and acquisitions (M&A).

EXPO Overview and Recent Performance

Exponent, Inc. (EXPO) operates as a science and engineering consulting firm, delivering expertise in areas like biomechanics, materials science, and regulatory services to industries including energy, transportation, and consumer products. Recent weeks have seen modest YTD performance around 4-5%, with shares hovering near $65-66 in a 52-week range of $63-82. The company maintains a solid balance sheet with low debt and strong margins (operating ~22.5%), reflected in a beta of 0.80 indicating lower market sensitivity. Anticipation builds for Q1 fiscal 2026 earnings due April 30, following a recent dividend increase to $0.31 per share. Performance has been influenced by steady demand for technical consulting amid regulatory and litigation needs, though slower revenue growth (4.5% quarterly YoY) and higher P/E valuation have capped upside amid broader industrials sector pressures.

Trending AI Robots

Tickeron’s Trending AI Robots page curates the top 25 AI trading bots from a library of 351, selected for their suitability to current market conditions across stocks, ETFs, and crypto. These bots employ diverse AI/ML strategies like trend trading, swing signals, and volatility plays, with timeframes from 5 minutes to 60 days. Performance highlights include annualized returns up to 163.65%, win rates ranging 51-88%, profit factors to 11.70, and profit-to-drawdown ratios exceeding 16 in top performers. Many incorporate risk controls such as 3% take-profit/2% stop-loss corridors and trade sectors relevant here, including financial services (e.g., GS), industrials, and semiconductors. Explore these bots to align automated strategies with your trading style and market outlook.

Head-to-Head Comparison

CBIZ and EXPO both thrive in professional services but diverge in focus: CBIZ on financial/insurance advisory versus EXPO's technical engineering niche, exposing CBZ more to M&A cycles and EXPO to R&D/litigation demands. Growth drivers differ—CBIZ benefits from organic revenue expansion and bolt-on deals, while EXPO leverages specialized expertise in high-barrier fields. Recent momentum favors CBZ with superior YTD gains, but EXPO offers stability via higher margins (19.75% profit) and lower beta. Risk factors include CBZ's elevated debt from acquisitions versus EXPO's conservative balance sheet (current ratio 2.40). Valuation tilts to CBZ's lower P/E and EV/EBITDA, amid similar sector headwinds like talent costs. Market sentiment leans positive for CBIZ's guidance raise, while EXPO's earnings await catalysts.

Tickeron AI Verdict

Tickeron’s AI models would likely favor CBZ in the current environment, given its stronger trend consistency, YTD outperformance exceeding 40%, recent earnings beat, and attractive valuation positioning relative to peers. EXPO's stability appeals probabilistically for risk-averse strategies, but CBZ's growth catalysts and momentum provide higher relative upside potential absent major disruptions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.